The GPhA Annual Policy Conference is the most important, issue-driven gathering of generic industry leaders and policy makers in the U.S. Each year, industry CEOs, FDA officials, members of Congress and industry analysts address the emerging challenges and opportunities that will shape the future of the generic pharmaceutical industry.

CEI Senior Fellow Greg Conko will be speaking on Thursday, September 18, the first day of the conference at 10:30am on the panel entitled "Biogenerics and Legislative Issues."  Joining Greg will be Anna Schwamlein-Howard, Senior Legislative Representative for
Federal Affairs/Health Issues for AARP along with Suzette Kox, Senior Director of Scientific Affairs for the European Generic medicines Association.